Patent details

EP2661261 Title: IMMUNOSUPPRESSANT FORMULATIONS

Basic Information

Publication number:
EP2661261
PCT Application Number:
EP2012050151
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP127002624
PCT Publication Number:
WO2012093161
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IMMUNOSUPPRESSANT FORMULATIONS
French Title of Invention:
FORMULATIONS D'IMMUNOSUPPRESSEURS
German Title of Invention:
IMMUNSUPPRESSIVE FORMULIERUNGEN
SPC Number:

Dates

Filing date:
05/01/2012
Grant date:
31/07/2019
EP Publication Date:
13/11/2013
PCT Publication Date:
12/07/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/07/2019
EP B1 Publication Date:
31/07/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/01/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/07/2019
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
BOUILLOT, Philippe
Address:
Switzerland (CH)

2

Name:
REYNAUD, Emeric
Address:
Switzerland (CH)

Priority

Priority Number:
11150431
Priority Date:
07/01/2011
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/20; A61K 31/397;

Publication

European Patent Bulletin

1

Issue number:
201931
Publication date:
31/07/2019
Description:
Grant (B1)

2

Issue number:
201935
Publication date:
28/08/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
30/12/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages